Clinicopathologic Significance of Cyclin A Expression in Colorectal Carcinoma

Tadahiro Nozoe, S. Inutsuka, M. Honda, T. Ezaki, D. Korenaga

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The clinical significance of cyclin A expression, which has been known to act in the mitotic phase of the cell cycle, as an indicator of malignant potential in human tumors, has been suggested. The aim of this study was to elucidate the significance of immunohistochemical expression of cyclin A in colorectal carcinomas based on a larger study population. Immunohistochemical staining for cyclin A was performed for 167 colorectal carcinomas and the correlation between cyclin A expression and the clinicopathological characteristics was analyzed. One hundred and two carcinomas (61.1%) had cyclin A expression and the other 65 (38.9%) did not. The mean size of the tumors with cyclin A expression was significantly larger than that of tumors without cyclin A expression (p = 0.012). Survival in patients with cyclin A-expressing carcinomas was significantly worse than that in patients with carcinomas without cyclin A expression (p = 0.004). Cyclin A expression (p = 0.030), as well as lymph node metastasis (p = 0.007) and Dukes' stage of the tumors (p < 0.0001) were found to be factors independently associated with unfavorable prognosis in patients with colorectal carcinoma. Our results demonstrated that immunohistochemical expression of cyclin A is an independent prognostic indicator in patients with colorectal carcinoma.

Original languageEnglish
Pages (from-to)127-133
Number of pages7
JournalJournal of Experimental and Clinical Cancer Research
Volume23
Issue number1
Publication statusPublished - Mar 1 2004

Fingerprint

Cyclin A
Colorectal Neoplasms
Carcinoma
Neoplasms
Cell Cycle
Lymph Nodes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Nozoe, T., Inutsuka, S., Honda, M., Ezaki, T., & Korenaga, D. (2004). Clinicopathologic Significance of Cyclin A Expression in Colorectal Carcinoma. Journal of Experimental and Clinical Cancer Research, 23(1), 127-133.

Clinicopathologic Significance of Cyclin A Expression in Colorectal Carcinoma. / Nozoe, Tadahiro; Inutsuka, S.; Honda, M.; Ezaki, T.; Korenaga, D.

In: Journal of Experimental and Clinical Cancer Research, Vol. 23, No. 1, 01.03.2004, p. 127-133.

Research output: Contribution to journalArticle

Nozoe, T, Inutsuka, S, Honda, M, Ezaki, T & Korenaga, D 2004, 'Clinicopathologic Significance of Cyclin A Expression in Colorectal Carcinoma', Journal of Experimental and Clinical Cancer Research, vol. 23, no. 1, pp. 127-133.
Nozoe, Tadahiro ; Inutsuka, S. ; Honda, M. ; Ezaki, T. ; Korenaga, D. / Clinicopathologic Significance of Cyclin A Expression in Colorectal Carcinoma. In: Journal of Experimental and Clinical Cancer Research. 2004 ; Vol. 23, No. 1. pp. 127-133.
@article{1d25c828be884175b5e9021e32d243f6,
title = "Clinicopathologic Significance of Cyclin A Expression in Colorectal Carcinoma",
abstract = "The clinical significance of cyclin A expression, which has been known to act in the mitotic phase of the cell cycle, as an indicator of malignant potential in human tumors, has been suggested. The aim of this study was to elucidate the significance of immunohistochemical expression of cyclin A in colorectal carcinomas based on a larger study population. Immunohistochemical staining for cyclin A was performed for 167 colorectal carcinomas and the correlation between cyclin A expression and the clinicopathological characteristics was analyzed. One hundred and two carcinomas (61.1{\%}) had cyclin A expression and the other 65 (38.9{\%}) did not. The mean size of the tumors with cyclin A expression was significantly larger than that of tumors without cyclin A expression (p = 0.012). Survival in patients with cyclin A-expressing carcinomas was significantly worse than that in patients with carcinomas without cyclin A expression (p = 0.004). Cyclin A expression (p = 0.030), as well as lymph node metastasis (p = 0.007) and Dukes' stage of the tumors (p < 0.0001) were found to be factors independently associated with unfavorable prognosis in patients with colorectal carcinoma. Our results demonstrated that immunohistochemical expression of cyclin A is an independent prognostic indicator in patients with colorectal carcinoma.",
author = "Tadahiro Nozoe and S. Inutsuka and M. Honda and T. Ezaki and D. Korenaga",
year = "2004",
month = "3",
day = "1",
language = "English",
volume = "23",
pages = "127--133",
journal = "Journal of Experimental and Clinical Cancer Research",
issn = "0392-9078",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Clinicopathologic Significance of Cyclin A Expression in Colorectal Carcinoma

AU - Nozoe, Tadahiro

AU - Inutsuka, S.

AU - Honda, M.

AU - Ezaki, T.

AU - Korenaga, D.

PY - 2004/3/1

Y1 - 2004/3/1

N2 - The clinical significance of cyclin A expression, which has been known to act in the mitotic phase of the cell cycle, as an indicator of malignant potential in human tumors, has been suggested. The aim of this study was to elucidate the significance of immunohistochemical expression of cyclin A in colorectal carcinomas based on a larger study population. Immunohistochemical staining for cyclin A was performed for 167 colorectal carcinomas and the correlation between cyclin A expression and the clinicopathological characteristics was analyzed. One hundred and two carcinomas (61.1%) had cyclin A expression and the other 65 (38.9%) did not. The mean size of the tumors with cyclin A expression was significantly larger than that of tumors without cyclin A expression (p = 0.012). Survival in patients with cyclin A-expressing carcinomas was significantly worse than that in patients with carcinomas without cyclin A expression (p = 0.004). Cyclin A expression (p = 0.030), as well as lymph node metastasis (p = 0.007) and Dukes' stage of the tumors (p < 0.0001) were found to be factors independently associated with unfavorable prognosis in patients with colorectal carcinoma. Our results demonstrated that immunohistochemical expression of cyclin A is an independent prognostic indicator in patients with colorectal carcinoma.

AB - The clinical significance of cyclin A expression, which has been known to act in the mitotic phase of the cell cycle, as an indicator of malignant potential in human tumors, has been suggested. The aim of this study was to elucidate the significance of immunohistochemical expression of cyclin A in colorectal carcinomas based on a larger study population. Immunohistochemical staining for cyclin A was performed for 167 colorectal carcinomas and the correlation between cyclin A expression and the clinicopathological characteristics was analyzed. One hundred and two carcinomas (61.1%) had cyclin A expression and the other 65 (38.9%) did not. The mean size of the tumors with cyclin A expression was significantly larger than that of tumors without cyclin A expression (p = 0.012). Survival in patients with cyclin A-expressing carcinomas was significantly worse than that in patients with carcinomas without cyclin A expression (p = 0.004). Cyclin A expression (p = 0.030), as well as lymph node metastasis (p = 0.007) and Dukes' stage of the tumors (p < 0.0001) were found to be factors independently associated with unfavorable prognosis in patients with colorectal carcinoma. Our results demonstrated that immunohistochemical expression of cyclin A is an independent prognostic indicator in patients with colorectal carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=2142761088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142761088&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 127

EP - 133

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

SN - 0392-9078

IS - 1

ER -